Stock INVA INNOVIVA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Innoviva, Inc.

Equities

INVA

US45781M1018

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-31 pm EDT 		5-day change 1st Jan Change
15.79 USD +2.87% Intraday chart for Innoviva, Inc. +0.06% -1.56%
May. 20 Zai Lab, Innoviva Subsidiary Receive China Approval for Hospital Infection Treatment MT
May. 15 Transcript : Innoviva, Inc. Presents at Bank of America Health Care Conference 2024, May-15-2024 09:20 AM

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Zai Lab, Innoviva Subsidiary Receive China Approval for Hospital Infection Treatment
MT
Earnings Flash (INVA) INNOVIVA Posts Q1 Revenue $77.5M
MT
Tranche Update on Innoviva, Inc.'s Equity Buyback Plan announced on November 9, 2022.
CI
Innoviva, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Innoviva, Inc.'s Equity Buyback announced on November 9, 2022, has closed with 7,807,887 shares, representing 11.78% for $100 million.
CI
Innoviva, Inc.'s Subsidiary Innoviva Specialty Therapeutics, Inc.?s Positive Phase 3 Oral Zoliflodacin Data for the Treatment of Uncomplicated Gonorrhea Announced at ESCMID Global 2024
CI
North American Morning Briefing : Stock Futures -2-
DJ
Tranche Update on Innoviva, Inc.'s Equity Buyback Plan announced on November 9, 2022.
CI
Earnings Flash (INVA) INNOVIVA Reports Q4 Revenue $85.8M
MT
Innoviva, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023
CI
Tranche Update on Innoviva, Inc.'s Equity Buyback Plan announced on November 9, 2022.
CI
Innoviva, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Earnings Flash (INVA) INNOVIVA Posts Q3 Revenue $67.3M
MT
Tranche Update on Innoviva, Inc.'s Equity Buyback Plan announced on November 9, 2022.
CI
Earnings Flash (INVA) INNOVIVA Reports Q2 Revenue $81M
MT
Innoviva, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
Innoviva Unit Says FDA Approves Xacduro for Treatment of Hospital-Acquired, Ventilator-Associated Bacterial Pneumonia
MT
Tranche Update on Innoviva, Inc.'s Equity Buyback Plan announced on November 9, 2022.
CI
Earnings Flash (INVA) INNOVIVA Posts Q1 Revenue $76.4M
MT
Innoviva, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. INVA Stock
  4. News Innoviva, Inc.
  5. Highlights